Abstract
Arteriogenesis is an important mechanism in improving the outcome of ischemic vascular diseases. However in patients who suffer from diabetes, this compensational collateral capacity is impaired. Hyperglycemia is the initial factor of diabetes induced vascular damage, but the mechanisms involved are poorly understood. The advanced glycation endproduct (AGE) precursor methylglyoxal (MGO) is a highly reactive oxo-aldehyde, which can be detoxified by the enzyme glyoxalase-I. We hypothesized that the reduced collateral artery remodeling capacity in diabetes is, at least partially, caused by intracellular glycation and defective regulation of the GLO-I enzyme.
Author information
Authors and Affiliations
Additional information
1Department of Internal Medicine, Maastricht University, 2Department of Radiology, Maastricht University, 3Department of Physiology, Maastricht University. E-mail: olaf.brouwers@maastrichtuniversity.nl
About this article
Cite this article
Yu, L., Brouwers, O., Niessen, P. et al. PS3 - 14. Glyoxalase-I overexpression partially prevents diabetes-induced impaired arteriogenesis in a rat hind limb ischemia model. NED. TIJDSCHR. DIABET. 9, 99–100 (2011). https://doi.org/10.1007/s12467-011-0039-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12467-011-0039-y